Loading…
← CockpitCompetitor Analysis › TTALO.HE Terveystalo Oy Class AOpen in the cockpit ↗

Terveystalo Oy Class ATTALO.HECompetitor analysis, valuation and peers

Finland · EUR·Health Care›Medical/Nursing Services

Finland's largest private healthcare provider, operating clinics and hospitals for general and occupational health.

Momentum laggard 10
Mkt cap
$832M
US dollars, full cap
Free float
63%
of shares outstanding
$/day
$1.53M
20-day average traded
Fwd P/E
10.7×
forward earnings
ROIC−WACC
+1.7 pp
WACC 5.0%
Hurdle
-10 pp
Req g minus delivered
Next earnings
86 days
12 Feb 2027
Close · EUR€6.00
1D-1.5%
1W-3.1%
1M-5.8%
3M-23.2%
6M-25.9%
YTD-38.6%
1Y-34.9%
ATR %2.3%
52w lowhigh42.4% off high

What Terveystalo Oy does

Finland's largest private healthcare provider, operating clinics and hospitals for general and occupational health.

Earns mainly from employers that buy occupational health care for their staff under recurring contracts, plus fees from private patients, insurers and public bodies that outsource care. Doctors and nurses are the main cost, so appointment capacity and staff availability set how much work it can book. Hospital and surgical work is the smaller add-on.

Products and services

  • General medical clinics
  • Occupational healthcare
  • Private hospital/surgical services

Customers

  • Individual patients
  • Employers (occupational health contracts)
  • Public sector (outsourced services)

Where it sits in the supply chain

  • Healthcare services
  • Private healthcare provider
  • Clinics + hospitals + occupational…

What could go right

  • Outsourcing of public healthcare services to private providers
  • Occupational health contract growth

What could go wrong

  • Staffing (doctor/nurse) cost inflation and shortages
  • Public healthcare policy/reimbursement changes

Moat: narrow (scale, brand, distribution). Largest private healthcare network in Finland gives scale in staffing, procurement and employer contracts.

Headquarters: Helsinki, Finland · Employees: 8,356

Named competitors

  • Pihlajalinna private or unlisted
  • Attendo ATT.ST
  • Mehilainen private or unlisted

Terveystalo Oy at a glance

Size Terveystalo Oy (TTALO.HE) is a Finland Health Care company (Medical/Nursing Services) with a market value of $832M, the 39th largest of 65 Finland companies the cockpit tracks. Shares closed at €6.00 on 18 Nov 2026.

Performance Over six months the shares fell 25.9%, against +0.9% for the median peer and -9.7% for the Finland market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue fell 8.3% over the last twelve months (peer median +5.2%); the operating margin is 8.3% (peer median 6.8%).

Valuation It trades at 10.7× forward earnings against a peer median of 19.8× (6th cheapest of 16).

Price implies For today's price to make sense, revenue must grow about -5% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is -10 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 1.7 points above its cost of capital (5.0% WACC).

Credit Terveystalo Oy has 1 bond outstanding ($144M).

Next results Next results expected around 12 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010021 May 202621 Aug 202618 Nov 2026Peer median 104TTALO.HE 74
Six months, rebased to 100: Terveystalo Oy against the median of its 20 peers (local-currency closes).

Terveystalo Oy financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€1.19B€1.28B€1.34B€1.29B€1.26B
Revenue growth—-5%+4%+2%—
Gross profit€230M€270M€260M€189M€168M
EBITDA€200M€234M€219M€175M€168M
Net income€57.3M€92.6M€71.7M-€42.2M€24.4M
Free cash flow€102M€156M€173M€114M€102M
Capital expenditure€54.9M€51.6M€39.6M€41.0M€59.2M
Total debt€717M€581M€570M€636M€607M

Quarterly statements and history in the cockpit →

Terveystalo Oy competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%0%+20%THYROCARE19594019514694REGGMRSNEPHROPLUSFLGTAHCO688315WELLGDRXNUTXMETROPOLISOPKPNTGDNADIACLARI301060TTALO.HE6-month return →1-month return →
Up and to the right = strong over both horizons. Terveystalo Oy is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%20×40×THYROCARE19594019514694REGGMRSNEPHROPLUS688315WELLGDRXNUTXMETROPOLISPNTGDIACLARITTALO.HERevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Terveystalo Oy is the large dot.

Capital: growth delivered against growth the price implies

0%+100%+200%0%100%200%THYROCARE19594019514694GMRSWELLGDRXNUTXTTALO.HEGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Terveystalo Oy is the large dot.

Terveystalo Oy competitors and peer comparison

Head to head with its named competitors (TTALO.HE vs ATT.ST)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Terveystalo Oy TTALO.HE$832M-26%-8%8%10.7×-5.1%
Attendo ATT.ST$1.87B+15%0%10%16.9×1.7%

How Terveystalo Oy compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Terveystalo Oy against its 20 peers (data as of 18 Nov 2026)
MeasureTTALO.HEPeer medianRank in peer set
1-month return-5.8%+1.5%7th lowest of 21
6-month return-25.9%+0.9%4th lowest of 21
Distance from 52-week high-42.4%-24.0%4th lowest of 21
Revenue growth (TTM)-8.3%+5.2%5th lowest of 21
Operating margin8.3%6.8%10th highest of 21
Forward P/E10.7×19.8×6th cheapest of 16
Growth the price implies (Req g, 7 yrs)-5.1%10.1%4th least demanding of 18
Growth delivered (Del g)+5.3%+12.2%4th lowest of 18
Hurdle (Req g minus delivered)-10.4 pp-1.1 pp7th least demanding of 18
ROIC minus cost of capital+1.7 pp-0.3 pp9th highest of 20
EV / EBITDA7.0×9.2×5th cheapest of 16
Net debt / EBITDA3.2×1.9×7th most indebted of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Terveystalo Oy TTALO.HEFinland$832M-26%-8%8%10.7×-5.1%+5.3%
Thyrocare Technologies THYROCARE.NSIndia$858M+7%+22%26%36.0×28.5%+10.9%
HK inno.N 195940.KSSouth Korea$783M-28%+7%12%12.3×-4.7%+12.2%
Jinxin Fertility 1951.HKHong Kong$758M-4%+7%11%23.1×17.8%+12.4%
BML 4694.TJapan$932M+12%+4%7%19.8×-9.0%+1.6%
Regis Healthcare REG.AXAustralia$962M-28%+17%4%25.3×13.3%+14.4%
GMR Solutions GMRSUnited States$714M-8%-4%14%5.9×-19.6%-4.0%
Nephrocare Health Services NEPHROPLUS.NSIndia$702M+1%+33%13%48.8×36.6%+31.6%
Fulgent Genetics FLGTUnited States$702M+53%+5%-38%n/an/an/a
AdaptHealth AHCOUnited States$1.01B-30%-3%3%n/a16.8%+25.2%
Novogene 688315.SSChina$1.01B+13%+6%7%44.8×13.9%+8.2%
WELL Health Technologies WELL.TOCanada$661M-9%+29%6%10.1×10.1%+94.5%
GoodRx GDRXUnited States$1.15B+33%-2%12%10.6×6.3%+7.7%
Nutex Health NUTXUnited States$1.19B+42%-19%39%6.5×-18.0%+253.5%
Metropolis Healthcare METROPOLIS.NSIndia$1.25B+11%+20%18%44.5×32.4%+10.5%
OPKO Health OPKUnited States$1.25B+37%-22%-29%n/an/an/a
Pennant PNTGUnited States$1.26B+1%+39%6%23.7×20.7%+19.4%
Ginkgo Bioworks DNAUnited States$547M+9%-44%-242%n/an/an/a
Diagnostyka DIA.WAPoland$1.28B-6%+19%15%19.5×7.3%+18.9%
Clariane CLARI.PAFrance$1.32B-20%+1%6%8.2×6.8%+6.5%
Shanghai Labway Clinical Laboratory 301060.SZChina$518M-17%-19%6%n/a5.9%+3.2%

Terveystalo Oy bonds and credit

Terveystalo Oy has 1 bond outstanding with $144M face value.

Every bond, yield and spread in the cockpit →

Questions

Who are Terveystalo Oy's main competitors?
Named competitors: Pihlajalinna (private or unlisted), Attendo (ATT.ST), Mehilainen (private or unlisted). The cockpit's measured peer set (industry) also includes Thyrocare Technologies (THYROCARE.NS), HK inno.N (195940.KS), Jinxin Fertility (1951.HK), BML (4694.T), Regis Healthcare (REG.AX), GMR Solutions (GMRS).
Is Terveystalo Oy expensive compared with its peers?
On forward p/e it trades at 10.7× against a peer median of 19.8×, 6th cheapest of 16 in its peer set. For today's price to make sense, revenue must grow about -5% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is -10 pp: the price already allows for a slowdown.
How has Terveystalo Oy stock performed?
Over six months to 18 Nov 2026 the shares returned -25.9% against +0.9% for the median peer; over one year -34.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.